Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Suzanne J. Baker has worked on the following 10 EPO patent applications which have been published in the last five years:

EP13162452

Vaccine

IPC classification:
A61K 39/09, A61K 39/102, A61K 39/145, A61K 39/295, A61K 39/39
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12720518

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

IPC classification:
A61K 39/09, A61P 31/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12721439

COMPOSITION COMPRISING A TLR AGONIST AND AN ANTIBODY SPECIFIC FOR AN ANTIGEN AND USES THEREOF AS VACCINE

IPC classification:
A61K 39/00, A61K 39/395, A61P 25/28
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13151470

Diamide Compounds having Muscarinic Receptor Antagonist and Beta 2 Adrenergic Receptor Agonist Activity

IPC classification:
A61K 31/444, A61P 11/00, A61P 11/08, C07D 401/12
Agent:
Suzanne J. Baker, GlaxoSmithKline
Agent:
Susan Margaret Scott, Abel & Imray
Status:
PATENT GRANTED
EP13710321

ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS

IPC classification:
A61K 31/4375, A61K 31/66, A61K 33/08, A61K 33/42, A61K 39/09, A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP11706840

TREATMENT OF STREPTOCOCCAL INFECTIONS

IPC classification:
A61K 39/00, A61K 39/09, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Agent:
Suzanne J. Baker, GlaxoSmithKline Intellectual Property Management Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15195398

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

IPC classification:
A61K 39/09
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15195408

VACCINE

IPC classification:
A61K 39/09, A61K 39/385
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15708341

USPA2 PROTEIN CONSTRUCTS AND USES THEREOF

IPC classification:
A61K 39/00, C07K 14/21, C07K 16/12
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP16183732

PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE

IPC classification:
A61K 39/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Suzanne J. Baker, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature